EMERPAND 4.6mg/24h transdermal patch ACTAVIS
rivastigmine Indicated for: Alzheimer's disease; dementia
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
letter E · page 14
rivastigmine Indicated for: Alzheimer's disease; dementia
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
rivastigmine Indicated for: Alzheimer's disease; dementia
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
ondansetron Indicated for: nausea and vomiting
ondansetron Indicated for: nausea and vomiting
ondansetron Indicated for: nausea and vomiting
prochlorperazine Indicated for: nausea and vomiting; psychotic disorders
N05AB04 Nervous system | Antipsychotics | Phenothiazines with piperazine structure
meclozine Indicated for: nausea, vomiting and motion sickness
galcanezumab Indicated for: migraine
coagulation factor VIII Indicated for: bleeding; coagulation disorders
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
coagulation factor VIII Indicated for: bleeding; coagulation disorders
B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
naproxen Indicated for: pain and inflammation
betahistine Indicated for: vertigo; vestibular disorders
betahistine Indicated for: vertigo; vestibular disorders
betahistine Indicated for: vertigo; vestibular disorders
ramipril Indicated for: hypertension
ramipril Indicated for: hypertension
ramipril Indicated for: hypertension
ramipril Indicated for: hypertension
ramipril + hydrochlorothiazide Indicated for: hypertension
C09BA05 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics
ramipril + hydrochlorothiazide Indicated for: hypertension
C09BA05 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics